Photo by Toa Heftiba on Unsplash

Serological modelling

Posts

Unpacking the blurred lines between biology, diagnosis, transmission, and immunity

Defining infection is like reading tarot cards - the interpretation depends on who’s asking and what they’re looking for. You wake up with a sore throat. You take a lateral flow test, negative. The next day, still negative. A PCR comes back “positive”. Meanwhile, your flatmate tested positive on a rapid test but felt fine throughout. So who was infected? You, your friend, both, or neither? It sounds simple, but defining someone as “infected” is not as clear-cut as it first appears.

Publications

A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data, validated with SARS-CoV-2 data from The Gambia.

This study explores how pre-vaccination HAI titres and vaccination history influence post-vaccine antibody responses in influenza vaccines. It finds that individuals with lower pre-vaccine antibody levels experience a larger and longer-lasting antibody boost after vaccination, while frequent vaccine recipients show a diminished response. The study emphasizes the importance of considering individual pre-vaccine antibody levels and vaccine history when interpreting post-vaccination antibody dynamics.

This study measures SARS-CoV-2 seroprevalence among UK healthcare workers following the first COVID-19 pandemic wave and explores risk factors and assay sensitivity.